Lindner Center of HOPE
Mason, Ohio, 45040, United States
NCT Number: NCT01090713
The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Phase 3
Mason, Ohio, 45040, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral; 20-70mg/day
20-70mg; oral
Time frame: 12 weeks
frequency of binge eating episode
Lindner Center of HOPE
Other
Lisdexamfetamine in Binge Eating Disorder of Moderate or Greater Severity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06807489
Anorexia Nervosa, Binge Eating Disorder
Stockholm, Sweden
View Trial DetailsNCT06604299
Binge Eating Disorder, Binge-Eating Disorder
The Bronx, New York, United States
View Trial DetailsNCT05897398
Bariatric Surgery, Binge Eating Disorder
Bondy, France
View Trial DetailsNCT03234881
Binge Eating Disorder, Binge-Eating Disorder
West Haven, Connecticut, United States
View Trial Details